Malignant Pleural Mesothelioma Post- Irradiation Treatment for Hodgkin’s Lymphoma Thea Price MD, R.V. Sooppan MD, Michael Walker MD Department of Thoracic.

Slides:



Advertisements
Similar presentations
Should pulmonary metastases from colorectal cancer be resected? Tom Treasure MD MS FRCS FRCP Clinical Operational Research Unit UCL (Department of Mathematics)
Advertisements

HCL Patient Seminar September 2014 Quality of Life Monica Else.
Incorporating Cesium-131 Interstitial Implants into Daily Clinical Practice: How to Make Radiation appear exactly where you want. Jonathan Feddock, MD.
Canadian Cancer Risk Management Model: A new health policy tool useful in policy decisions related to lung cancer WK Evans, M Wolfson, WM Flanagan, J Oderkirk,
The Value of a Chest X-Ray in Diagnosing Pneumonia in SIRS Patients Lacking Respiratory Symptoms in York Hospital’s Emergency Department Michelle Lynch.
Matthew Kilmurry, M.D. St. Mary’s General Hospital Grand River Hospital.
Improving Life, One Breath at a Time LUNG-USAwww.lunginfo.org.
Screen discovered nodules: What next? Anil Vachani, MD, MS Assistant Professor of Medicine Director, Lung Nodule Program University of Pennsylvania Medical.
By Rachel, Xiao Xia, Helen. Introduction Definition Symptoms Causes Prevention Treatment Prognosis Statistics Conclusion.
DIFFUSE MALIGNANT MESOTHELIOMA GENERAL THORACIC SURGERY CHAPTER 65.
A Survey of Quality of Life Following Surgery for Malignant Pleural Mesothelioma: Reflects the patients’ commitment to Learning about the Disease D A Raffle,
The role of surgery in the management of mesothelioma Mr Martyn Carr Consultant Thoracic Surgeon Liverpool Heart and Chest Hospital.
Mesothelioma. Is a malignant tumour of pleura, usually resulting from asbestos exposure. Asbestos is the major single cause and there is a history of.
Cost-Conscious Care Presentation Follow-up Chest X-Ray in Patients Admitted for Community Acquired Pneumonia Huy Tran, PGY-2 12/12/2013.
The Contribution of Mental Health Services to Tackling Health Inequalities Dr Alastair Cook Chair RCPsych in Scotland.
TYPES, CAUSES, SYMPTOMS, TREATMENTS, STATISTICS, & PICTURES HEATHER XXXXXXX, 1 ST PERIOD Lung Cancer 1
® Introduction Low Back Pain Remedies and Procedures: Helpful or Harmful? Lauren Lyons, Terrell Benold, MD, Sandra Burge, PhD The University of Texas Health.
MESOTHELIOMA IS A RARE CANCER THAT OCCURS IN THE THIN LAYER OF TISSUE THAT COVERS THE MAJORITY OF YOUR INTERNAL ORGANS.
Hypofractionated Radiation Therapy for Early Stage Breast Cancer Patrick J. Gagnon, M.D. Resident, PGY-4 Radiation Medicine, OHSU Providence Hospital Breast.
The Miracle of EM-X Therapy in Breast Cancer. Professor Khalida Usmani M.B.B.S, M.D, F.R.C.S Founder Cancer Research Foundation of Pakistan President,
The Effect of Chest Wall Injuries on Morbidity and Mortality in the Elderly Cierra Jenkins 1, Dr. Ronald Benenson M.D 1,2. 1 Department of Biological Sciences,
50 year old man with history of Hodgkin Lymphoma as a child, treated with mediastinal radiation, now presenting with severe heart failure.
By: Rusita, Jimmy, and Bobby. History  Lung cancer is a disease characterized by uncontrolled cell growth in the tissue of the lung.  People who smoke.
 Smoking is the primary cause of avoidable death  Thousand of teens try cigarettes daily.  Smoking contributes to an astonishing number of diseases.
Management of Rib Fractures. Clinical Anatomy 12 pairs of ribs Attach posteriorly to vertebrae Rib 8-12 are “false ribs” Ribs 1-3 are relatively well.
A Retrospective Study of the Association of Obesity and Overweight with Admission Rate within York Hospital Emergency Department for Acute Asthma Exacerbations.
Breast Cancer. What is this Disease? Second leading cause of cancer death in women Malignant (cancerous) tumor –Develops from cells in the breast that.
Matthew S. Slater, MD, Brian S. Diggs, PhD Frederick A. Tibayan, MD Steven G Guyton, MD, MPH Howard K. Song, MD, PhD The Department of Surgery, and the.
A 44 year old woman with breast pain……… March 10, 2004 Primary Care Conference Shobhina Chheda MD MPH (no financial disclosures)
Chondrosarcoma of the chest wall: primary diagnostics is decisive for outcome Björn Widhe and Henrik Bauer.
Pulmonary Embolism Treatment in Cancer - Is It Different 34th Brazilian Thoracic Conference 6th ALAT Congress 5th Brazil-Portugal Congress Brazilia/DF.
THORACIC CLUB MEETING AHMADU BELLO UNIVERSITY TEACHING HOSPITAL,ZARIA,NIGERIA PLEURAL TUMORS.
® Introduction Changes in Opioid Use for Chronic Low Back Pain: One-Year Followup Roy X. Luo, Tamara Armstrong, PsyD, Sandra K. Burge, PhD The University.
Strokes in Ascending Aortic Repairs: Predictive and Protective Factors Tovy Kamine, BS, Steven R Messé, MD, Elizabeth Leitner, Joseph Bavaria, MD, Michael.
SUBSEQUENT HEALTHCARE UTILIZATION ASSOCIATED WITH EARLY PHYSICAL THERAPY FOR NEW EPISODES OF LOW BACK PAIN IN OLDER ADULTS Deven Karvelas, MD University.
Morgagni Hernia Brian Belyea Radiology Elective Block 8 February 27, 2004.
Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma Marc de Perrot, Ronald Feld, Natasha B Leighl,
بسم الله الرحمن الرحيم. Adult Hodgkin’s Lymphoma in the Eastern Part of Libya Dr. M.Mangoush, R. Nafo, S.Kardah, M.Letaiwish, S.Kardah, F.Bodabous, S.Ebkhatra.
Mesothelioma BY: Savannah Field & Emily Zahn. OUTLINE Vocabulary Background Information Population Affected Symptoms Diagnosis Treatment Conclusion Works.
Worcester and Wyre Forest Pleural Disease Service Dr. Clare Hooper Consultant Respiratory Physician Worcestershire Acute Hospitals NHS Trust.
Breast Cancer 1. Leukemia & Lymphoma New diagnoses each year in the US: 112, 610 Adults 5,720 Children 43,340 died of leukemia or lymphoma in
Caitlyn Ryan, Summer Research Intern Andrew R. Doben, M.D.
Quality Management in the ICU Mazen Kherallah, MD, FCCP Chairman, Critical Care Department King Faisal Specialist Hospital & Research Center.
Prevalence and clinical risk factors for interstitial lung disease in rheumatoid arthritis in a resource limited setting A Dasgupta, P Bhattacharyya, S.
Brain imaging prior to lung cancer resection
CRT 2012 Venous Disease.
The Uganda Cancer Institute Experience Walusansa Victoria.
DETERMINING RISK FOR ASBESTOS-RELATED MALIGNANCY: LUNG CANCER
A Hussain, S Qadri, Y Haqzad, M Chaudhry, A Cale, M Cowen, M Loubani.
2nd Eurasian Respiratory and Allergy Summit
Screening for Malignant Pleural Mesothelioma and Lung Cancer in Individuals with a History of Asbestos Exposure  Heidi C. Roberts, MD, Demetris A. Patsios,
Prognostic Factors in the Treatment of Malignant Pleural Mesothelioma at a Large Tertiary Referral Center  Raja M. Flores, MD, Maureen Zakowski, MD, Ennapadam.
Volume 102, Issue 3, Pages (September 1992)
Treatment of Malignant Pleural Effusion
Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma  Marc de Perrot, MD, MSc, Ronald Feld, MD,
This patient with a malignant pleural effusion was treated with an indwelling pleural catheter (IPC). This patient with a malignant pleural effusion was.
by Petri Salven, Lasse Teerenhovi, and Heikki Joensuu
Patient charactaristics:
Satya Shanbhag Waikato Cardiothoracic Unit
CT images of a patient with mesothelioma who developed catheter tract metastasis around his indwelling pleural catheter (IPC), which was in place for 5 months.
Breast Cancer.
Ali F. AbuRahma, MD  Journal of Vascular Surgery 
Anthony Lemaire, MD, William R
Effects of Extended Pleurectomy and Decortication on Quality of Life and Pulmonary Function in Patients With Malignant Pleural Mesothelioma  David Burkholder,
Axial CT scans of the chest. a) Before treatment
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Prognostic Factors in the Treatment of Malignant Pleural Mesothelioma at a Large Tertiary Referral Center  Raja M. Flores, MD, Maureen Zakowski, MD, Ennapadam.
Screening for Malignant Pleural Mesothelioma and Lung Cancer in Individuals with a History of Asbestos Exposure  Heidi C. Roberts, MD, Demetris A. Patsios,
Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis  Mariette Baud, MD, Salvatore Strano, MD, PhD, Agnes.
Proton Therapy for Thymic Malignancies: Multi-institutional Patterns-of-Care and Early Clinical Outcomes from the Proton Collaborative Group Registry &
Presentation transcript:

Malignant Pleural Mesothelioma Post- Irradiation Treatment for Hodgkin’s Lymphoma Thea Price MD, R.V. Sooppan MD, Michael Walker MD Department of Thoracic Surgery Thomas Jefferson University Hospital Eastern Cardiothoracic Surgical Society Annual Meeting October 23-36, 2013

Introduction: Malignant Pleural Mesothelioma (MPM) Long latency period (10-40 years) 85% from environmental exposure (asbestos) 15% arise without environmental exposure 2 nd primary malignancies 30-fold increase risk after irradiation (XRT) treatment for Hodgkin Lymphoma (HL) Asbestos

Patient Data Patient Age of HL Dx Age of MPM Dx XRTXRT Chemo Asbestos exposure Type MPM 1) Female Epithelioid 2) Male Epithelioid

Radiology Patient 2: PET Patient 1 : PET

Conclusions Extended Field Radiation utilized in the 1970s and 1980s, especially in adolescents, significantly raises the risk of second primary malignancy ≥ 30 years later 77% of deaths >10 from HL related to longterm effects of therapy* Often widespread invasion at diagnosis Natural history of death within 4-12 months of diagnosis Vitally important to recognize this risk in HL patients presenting with respiratory symptoms or chest pain Acknowledgements Dr. Michael Walker, MD, Thoracic Surgery Department, Main line Health, Pennsylvania Jefferson University Hospitals, Philadelphia, Pennsylvania Yung L, et al. Long term outcome in adolescents with Hodgkin's lymphoma: poor results using regimens designed for adults. Leuk Lymphoma Aug;45(8):